Page 297 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P1016 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ePOSTERS
P1017 FATTY LIVER OR GLUCOSE INTOLERANCE
P1018 Akio Moriya*,Yoshiaki Iwasaki, Souhei Ohguchi, Eizo Kayashima,
P1019 Tadahiko Mitsumune, Hideaki Taniguchi, Masaharu Ando, Japan

P1020 CIRCULATING SCLEROSTIN AND DICKKOPF-1 IN
P1021 PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
P1022 Stergios A. Polyzos, Athanasios D. Anastasilakis, Evangelos Terpos,
Polyzois Makras, Athanasios Papatheodorou, Panagiotis Kokkoris,
Jannis Kountouras*, Greece

SIGNIFICANT CORRELATION BETWEEN VISCERAL FAT
AREA AND CONTROLLED ATTENUATION PARAMETER
Kyu Sik Jung*, Kwang Joon Kim, Jun Yong Park,Young Eun Chon,
Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn,
Kwang-Hyub Han, South Korea

THE IMPACT OF METABOLIC SYNDROME ON ALT LEVELS
AMONG THE LARGE MULTIETHNIC COHORT OF NORTH
AMERICAN PATIENTS WITH CHRONIC HEPATITIS B
INFECTION ENROLLED IN THE HEPATITIS B RESEARCH
NETWORK (HBRN)
Mandana Khalili*, Manuel Lombardero, Jordan Feld, Margaret Shuhart,
Raymond Chung, Norah Terrault, Kris Kowdley, Mauricio Lisker-
Melman, Marc Ghany, W. Ray Kim, Arun Sanyal, Anna Lok,
The United States

EFFECTS OF URSODEOXYCHOLIC ACID AND
PIOGLITAZONE LONG THERAPY ON HEPATOCYTES
CHANGES IN NASH PATIENTS
Nataliya Virstyuk*, Olena Deltsova, Sergii Geraschenko,
Larysa Kovalchuk, Ukraine

EFFECTS OF URSODEOXYCHOLIC ACID AND
PIOGLITAZONE LONG THERAPY ON NASH COURSE
Nataliya Virstyuk*, Olena Deltsova, Sergii Geraschenko, Ukraine

FIBRO SCAN AND COGNITIVE DYSFUNCTION IN OBESE
INDIVIDUALS WITH METABOLIC RISK FACTORS
Nimer Assy*, Alaa Abosaleh, Hussam Assly, Masha Grosovski,
Nelly Bar Guy, Israel, Italy

Vienna, Austria • April 22–26, 2015 297